These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2083158)

  • 1. Immunologic aspects of scleroderma.
    Korn JH
    Curr Opin Rheumatol; 1990 Dec; 2(6):922-8. PubMed ID: 2083158
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic aspects of scleroderma.
    Korn JH
    Curr Opin Rheumatol; 1989 Dec; 1(4):479-84. PubMed ID: 2702049
    [No Abstract]   [Full Text] [Related]  

  • 3. Are endothelial cells stimulated by autoantibodies in scleroderma?
    Nunzi E; Rebora A
    Acta Derm Venereol; 1983; 63(5):458-9. PubMed ID: 6197854
    [No Abstract]   [Full Text] [Related]  

  • 4. Scleroderma: a disease related to damaged proteins?
    Peng SL; Fatenejad S; Craft J
    Nat Med; 1997 Mar; 3(3):276-8. PubMed ID: 9055850
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticentriole antibody-positive limited cutaneous systemic sclerosis.
    Nozaki H; Kishibe M; Kanno K; Igawa S; Saito T; Shimamura T; Minami-Hori M; Honma M; Ishida-Yamamoto A
    J Dermatol; 2017 Jun; 44(6):e119-e120. PubMed ID: 28186355
    [No Abstract]   [Full Text] [Related]  

  • 6. Is scleroderma an autoantibody mediated disease?
    Arnett FC
    Curr Opin Rheumatol; 2006 Nov; 18(6):579-81. PubMed ID: 17053501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic sclerosis, pulmonary fibrosis and anti-MPO antibodies.
    Hidalgo-Tenorio C; Càliz R; Gallego M; Jaimez L; Jiménez-Alonso J
    Clin Rheumatol; 2005 Nov; 24(6):658-60. PubMed ID: 15719151
    [No Abstract]   [Full Text] [Related]  

  • 8. [Autoantibodies in systemic sclerosis (scleroderma)].
    Greenbaum E; Laufer M; Shoenfeld J
    Harefuah; 1993 Mar; 124(6):370-4. PubMed ID: 8388360
    [No Abstract]   [Full Text] [Related]  

  • 9. [Polymyositis/scleroderma autoantibody-positive scleroderma with dermatomyositis (scleromyositis)].
    Török L; Dankó K; Cserni G; Szücs G
    Orv Hetil; 2002 Nov; 143(45):2553-6. PubMed ID: 12501562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies in scleroderma.
    Rothfield NF
    Rheum Dis Clin North Am; 1992 May; 18(2):483-98. PubMed ID: 1626078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticentriole antibody in a patient with progressive systemic sclerosis.
    Osborn TG; Ryerse JS; Bauer NE; Urhahn JM; Blair D; Moore TL
    Arthritis Rheum; 1986 Jan; 29(1):142-6. PubMed ID: 3511919
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoantibody to RNA polymerase I in scleroderma sera.
    Reimer G; Rose KM; Scheer U; Tan EM
    J Clin Invest; 1987 Jan; 79(1):65-72. PubMed ID: 2432091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic aspects of scleroderma.
    Korn JH
    Curr Opin Rheumatol; 1991 Dec; 3(6):947-52. PubMed ID: 1772749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma).
    Reimer G
    Rheum Dis Clin North Am; 1990 Feb; 16(1):169-83. PubMed ID: 2406806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Scleroderma: Bringing a Disease From Black-and-White Into Technicolor.
    Ligon CB; Wigley FM
    Arthritis Rheumatol; 2015 Dec; 67(12):3101-3. PubMed ID: 26245737
    [No Abstract]   [Full Text] [Related]  

  • 16. Scleroderma.
    Gabrielli A; Avvedimento EV; Krieg T
    N Engl J Med; 2009 May; 360(19):1989-2003. PubMed ID: 19420368
    [No Abstract]   [Full Text] [Related]  

  • 17. Connective tissue diseases: New criteria improve recognition of early systemic sclerosis.
    Asano Y; Sato S
    Nat Rev Rheumatol; 2015 Jan; 11(1):3-4. PubMed ID: 25385415
    [No Abstract]   [Full Text] [Related]  

  • 18. [The immunophysiological and immunopathological aspects of scleroderma systematica: fundamental and clinical aspects].
    Khitrov AN; Gracheva TS; Isaeva MA; Grishina TI; Shoenfeld Y; Velichkovskiĭ BT; Suchkov SV
    Patol Fiziol Eksp Ter; 2007; (1):21-7. PubMed ID: 17526213
    [No Abstract]   [Full Text] [Related]  

  • 19. The aetiopathogenesis of systemic sclerosis.
    Black CM
    J Intern Med; 1993 Jul; 234(1):3-8. PubMed ID: 8326286
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
    Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
    Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.